You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
愛朋醫療(300753.SZ):擬斥3850萬元收購百士康70%股權 完成慢性疼痛領域產品及渠道佈局
格隆匯 04-25 18:39

格隆匯4月25日丨愛朋醫療(300753.SZ)宣佈,為進一步豐富疼痛管理醫療器械領域產品及服務生態圈,拓展慢性疼痛領域市場,公司全資子公司江蘇愛朋醫療科技發展有限公司(簡稱“愛朋發展”)擬收購深圳市百士康醫療設備有限公司(簡稱“百士康”)70%股權,完成慢性疼痛領域產品及渠道佈局。經友好協商,愛朋發展出資人民幣3850萬元,受讓百士康70%股權,對應註冊資本350萬元,成為百士康控股股東。

2021年4月23日,愛朋發展及南通瑞真管理諮詢合夥企業(有限合夥)與百士康控股股東贛州筋康智科企業管理中心(有限合夥)簽訂了《股權轉讓協議》。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account